CSL - Bénéfice Avant Impôts

Prix De L'Action
140.23
Variation Quotidienne
-1.95 -1.37%
Mensuellement
-3.00%
Annuel
-42.00%
Q2 Prévisions
135.92




Bénéfice Avant Impôts Changement Date
Alterity Therapeutics Limited AUD -4.74M 3.53M 2024-12
Arca Biopharma USD -29.58M 694K 2025-12
aTyr Pharma USD -25.75M 6.22M 2025-09
Bio Path USD -976K 3.62M 2025-09
Brainstorm Cell Therapeutics USD -2.11M 797K 2025-09
Cara Therapeutics USD -4.91M 3.17M 2025-03
CSL USD 2.61B 1.21B 2025-12
Curis USD 19.36M 33.34M 2025-12
Esperion Therapeutics USD 63.67M 95M 2025-12
Immunic USD -21.38M 8.2M 2024-06
Infinity Pharmaceuticals USD -9.96M 1.09M 2023-06
Minerva Neurosciences USD 22.51M 30.74M 2024-09
Sangamo BioSciences USD -36.05M 12.94M 2024-06
TherapeuticsMD USD -1.05M 241K 2024-06